检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
作 者:唐三元[1] 黄卫国[2] 朱媛[1] 苏菊[1] 陈琳[1] 殷耒兰 李跃华[1]
机构地区:[1]南华大学附属第一医院肿瘤内科,湖南衡阳421001 [2]南华大学肿瘤研究所
出 处:《中南医学科学杂志》2013年第5期437-439,444,共4页Medical Science Journal of Central South China
基 金:国家自然科学基金(81172210);湖南省自然科学衡阳联合基金(10JJ9017)
摘 要:目的通过顺铂(cDDP)浓度递增法建立鼻咽癌耐药的细胞株CNE2/cDDP,并研究其耐药性变化。方法采用cDDP浓度递增法建立鼻咽癌顺铂耐药细胞系CNE2/cDDP,倒置显微镜进行形态学观察,MTT检测CNE2/cDDP细胞系对不同化疗药物的耐药性。结果 MTT研究发现在不同药物(顺铂、长春新碱、卡铂、紫杉醇、5-FU)作用下,CNE2/cDDP较CNE2的IC50值及耐药指数均有明显的增加,CNE2/cDDP细胞对顺铂的耐药性最强,增加到200.6倍,对5-Fu的耐药性最差,增加到2.8倍;耐药细胞株CNE2/cDDP较非耐药细胞株CNE2生长速度减慢,其细胞倍增时间由18 h增加到24 h;CNE2/cDDP细胞体积较CNE2为小,常呈克隆聚集现象。结论CNE2/cDDP具有多药耐药性,是一个理想的用于鼻咽癌的多药耐药研究的细胞系。Objective To study the changes of drug resistence of NPC by establishing the cis-Diammine-Dichloro- Platinum (eDDP) -resistant NPC cell lines (CNE2/eDDP) through eDDP concentration progressively increased method. Methods CNE2/cDDP was established by cDDP concentration progressively increased method. Morphology study was per- formed by invert microscope, and drug resistance to eDDP, Vincristin, Carboplatin, Taxotere, and 5-fluorouracil were detected by MTT. Results MTT showed that there was significant increase of IC50 and resistance index in CNE2/eDDP compared to CNE2, after dealt with cDDP, Vineristin, Carboplatin, Taxotere, and 5-fluorouracil. And the drug resistance of eDDP in CNE2/eDDP was the highest, and RI (resistance index) was increased to 200.6-folds compared to CNE2. While the lowest drug resistance was in 5-Fu, and RI was increased to 2.8-folds compared to CNE2. There were clone aggregation and slow growth speed in CNE2/cDDP and more longer doubling time increased from 18 h in CNE2/cDDP to 24 h in CNE2. And there were much smaller volume in CNE2/cDDP compared with CNE2. Conclusion CNE2/cDDP may serve as an ideal cell line used for study of drug resistance in NPC for its multi-drug resistance.
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:216.73.216.175